IP Library Granted Patent US 9,872,949
Granted Patent B2
US 9,872,949 · App. 15/449,015 · Granted Jan 23, 2018

Systems and methods for multifunctional volumetric fluid control

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,872,949
App. No.
15/449,015
Granted
Jan 23, 2018
Kind
B2
Abstract

Systems and methods for controlling fluid movement and volumes of fluid between a subject and a controlled compliant flow path. The controlled compliant flow path has a means for selectively metering in and metering out fluid from the controlled compliant flow path. An extracorporeal flow path is in fluid communication with the controlled compliant flow path across a semi-permeable membrane where the extracorporeal flow path has a first terminal end and a second terminal end.

Claims (33)

1. A system for performing any one of hemodialysis, hemodiafiltration, hemofiltration, comprising:

a controlled compliant flow path comprising a dialyzer;

at least a first pump in fluid communication with the controlled compliant flow path;

a common reservoir in fluid communication with the first pump, wherein the common reservoir contains any one of a dialysate, a filtrate, a volume of a physiologically compatible priming solution, a volume of a physiologically compatible solution to provide a bolus of fluid to a subject receiving treatment, a volume of physiologically compatible solution to provide solution for return of blood from an extracorporeal flow path to a subject receiving treatment, a volume of solution returned to the common reservoir from an extracorporeal flow path when blood from a subject is introduced to the extracorporeal flow path, and combinations thereof;

at least a second pump in fluid communication with the controlled compliant flow path and either a fluid source or a reservoir; wherein the second pump is a water pump in fluid communication with a water source;

the at least first pump and at least second pump for selectively metering in and metering out fluid from the controlled compliant flow path;

at least one sensor measuring a sodium content of a fluid in the controlled compliant flow path;

a controller programmed to determine the sodium content of the fluid in the controlled compliant flow path and to control the second pump based at least in part on the sodium content of the fluid in the controlled compliant flow path;

the at least first pump and at least second pump operable in concert to control net fluid movement into and out of the controlled compliant flow path, wherein the at least first pump and at least second pump are coordinately operated by the controller applying an instantaneous rate of fluid removal to a control algorithm.

2. The system of claim 1 , further comprising at least one pump selected from the group consisting of, an acid concentrate pump, a salination pump, a replacement fluid pump, and combinations thereof.

3. The system of claim 1 , wherein the controller applies the control algorithm to obtain the net volume of fluid added to and/or removed from a patient during therapy:

Σ i=0 n X i =patient fluid balance;

wherein n is a number of pumps fluidly connected to the controlled compliant flow path, i refers to a specific pump fluidly connected to the controlled compliant flow path, and X i is volumetric flow rate of a pump in either an influx or efflux direction; wherein is negative when pump i is operated in the efflux direction and positive when pump i is operated in an influx direction.

4. The system of claim 3 , wherein the controller controlling each pump to accomplish a predetermined patient fluid balance.

5. The system of claim 1 , further comprising a semi-permeable membrane, wherein the extracorporeal flow path is in fluid communication with the controlled compliant flow path across the semi-permeable membrane wherein the extracorporeal flow path has a first terminal end and a second terminal end.

6. The system of claim 5 , wherein the first terminal end and the second terminal end are connectable together to form a junction.

7. The system of claim 6 , wherein the junction is between the terminal ends of an arterial line and a venous line of an extracorporeal circuit.

8. The system of claim 5 , wherein the extracorporeal flow path has a blood pump for circulating blood through the extracorporeal flow path, and a first valve and/or a second valve to selectively permit flow through a first conduit and a second conduit in fluid communication across either a dialyzer or hemofilter on the extracorporeal flow path.

9. The system of claim 5 , further comprising a first valve and/or a second valve, wherein at least the first pump coordinately operates with the first valve and/or the second valve to control fluid movement.

10. The system of claim 8 , wherein at least the blood pump coordinately operates with the first and/or second valve to control fluid movement.

11. The system of claim 8 , wherein the first pump and the blood pump on the extracorporeal flow path coordinately operate with the first valve and/or second valve to control fluid movement.

12. The system of claim 6 , wherein the extracorporeal flow path has a hydrophobic vent or a priming overflow reservoir connected to the junction.

13. The system of claim 5 , further comprising a sorbent cartridge on the controlled compliant flow path wherein a fluid passes through the sorbent cartridge prior to crossing the semi-permeable membrane.

14. The system of claim 5 , further comprising a microbial filter on the controlled compliant flow path wherein fluid passes through the microbial filter prior to crossing the semi-permeable membrane.

15. The system of claim 5 , further comprising a microbial filter on the controlled compliant flow path wherein fluid passes through the microbial filter prior to entering the extracorporeal flow path.

16. The system of claim 5 , further comprising at least one bubble detector to detect air in the extracorporeal flow path at any one of a first conduit, a second conduit, or both.

17. The system of claim 5 , wherein the controlled compliant flow path has a means for conductivity measurement to verify that a sodium content is within predetermined limits.

18. The system of claim 5 , wherein the controlled compliant flow path has a means for adjusting the solute concentration of fluid in the controlled compliant flow path.

19. The system of claim 18 , wherein the means for adjusting the solute concentration of fluid in the controlled compliant flow path is a sodium chloride source that can increase a sodium chloride concentration of fluid passing through the controlled compliant flow path and a buffer source that can increase a buffer concentration of fluid passing through the controlled compliant flow path.

20. The system of claim 18 , wherein the means for adjusting the solute concentration of fluid in the controlled compliant flow path is a sodium chloride cartridge that can increase a sodium chloride concentration of fluid passing through the cartridge and a buffer source cartridge that can increase a buffer concentration of fluid passing through the buffer source cartridge.

21. The system of claim 1 , wherein the at least one pump operates in a single direction to meter a controlled volume of a first fluid from the controlled compliant flow path and to return an equal volume of a second fluid to the controlled compliant flow path.

22. The system of claim 21 , wherein the second fluid contains a saline concentration different from the first fluid.

23. The system of claim 1 , wherein the controlled compliant flow path has a substantially inflexible volume.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: MEDTRONIC, INC.
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2017
From: MEYER, THOMAS E.; LURA, DAVID B.; PUDIL, BRYANT J.; GERBER, MARTIN T.
To: MEDTRONIC, INC.
Reel/Frame 041460/0140 →